Evidence map›Paper›PMID 24843574›Full record

ArticleJournal of diabetes investigation2012

Hemoglobin A1c for the diagnosis of diabetes: To replace or to guide oral glucose tolerance tests?

Hung-Yuan Li, Wen-Ya Ma, Jung-Nan Wei, Mao-Shin Lin, Shyang-Rong Shih, Chi Sheng Hung, Cyue-Huei Hua, Lee-Ming Chuang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hung-Yuan LiDepartment of Internal Medicine, National Taiwan University Hospital ; Graduate Institute of Clinical Medicine, Medical College, National Taiwan University.
Wen-Ya MaDivision of Endocrinology, Department of Internal Medicine, Cardinal Tien Hospital, Medical School, Catholic Fu Jen University.
Jung-Nan WeiChia Nan University of Pharmacy and Science, Tainan.
Mao-Shin LinDepartment of Internal Medicine, National Taiwan University Hospital ; Graduate Institute of Clinical Medicine, Medical College, National Taiwan University.
Shyang-Rong ShihDepartment of Internal Medicine, National Taiwan University Hospital ; Graduate Institute of Clinical Medicine, Medical College, National Taiwan University.
Chi Sheng HungDepartment of Internal Medicine.
Cyue-Huei HuaDivision of Clinical Pathology, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
Lee-Ming ChuangDepartment of Internal Medicine, National Taiwan University Hospital ; Graduate Institute of Clinical Medicine, Medical College, National Taiwan University ; Graduate Institute of Preventive Medicine, National Taiwan University School of Public Health, Taipei.
National Taiwan University · TWCardinal Tien Hospital · TWChia Nan University of Pharmacy and Science · TWNational Taiwan University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledAims/Introduction:  To evaluate if hemoglobin A1c (A1C) can replace the use of the oral glucose tolerance test (OGTT) to diagnose diabetes in Chinese patients. MATERIALS AND

methodsSubjects without pre-existing diabetes were included in this community-based study. Each participant received a 75-g OGTT and A1C tests.

resultsA total of 1362 subjects, 512 men and 850 women, aged 18-88 years, were enrolled. The prevalence of diabetes was 7.4 and 7.3% by OGTT and by A1C ≥ 6.5% criteria, respectively. The optimal A1C cut-off for diabetes defined by OGTT was 6.1%. The performance of A1C ≥ 6.1% to find diabetes by OGTT was poor, with a kappa 0.50, sensitivity 80% and specificity 91%. Using current criteria of fasting plasma glucose (FPG) < 5.56 mmol/L to exclude and ≥7 mmol/L to diagnose diabetes (FPG criterion), the sensitivity, specificity and OGTT required were 77.2, 100 and 13.5%, respectively. Using A1C < 5.9% to exclude and ≥7.0% to diagnose diabetes (A1C criterion), the sensitivity, specificity and OGTT required were 89.1, 99.8 and 26.5%, respectively. However, using FPG < 5.56 mmol/L and A1C < 6.1% to exclude, and A1C ≥ 7.0% to diagnose diabetes (A1C plus FPG criterion), the sensitivity, specificity and OGTT required were 85.2, 100 and 18.9%, respectively.

conclusionsTo screen for diabetes, the A1C criterion is more sensitive than the FPG criterion, with more OGTT needed. The A1C plus FPG criterion reduced the number of OGTT needed with acceptable sensitivity. A1C can guide, but cannot replace, OGTT to diagnose diabetes. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00181.x, 2011).

Indexed as

DiagnosisHemoglobin A1cOral glucose tolerance test

Identifiers

PMID24843574
PMCPMC4014947
OpenAlexW2152622111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.